Cargando…

Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia

Therapeutic options for relapsed/refractory B-cell acute lymphoblastic leukemia have evolved in the past few years. The FDA has approved three novel therapies for this disease: inotuzumab ozogamicin (an anti-CD22 antibody–drug conjugate), blinatumomab (a bispecific T-cell engager), and chimeric anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conde-Royo, Diego, Juárez-Salcedo, Luis Miguel, Dalia, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560100/ https://www.ncbi.nlm.nih.gov/pubmed/33110433 http://dx.doi.org/10.7573/dic.2020-7-2

Ejemplares similares

Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature
por: Juárez-Salcedo, Luis Miguel, et al.
Publicado: (2020)

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab, Tareq, et al.
Publicado: (2021)

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia
por: Guerra, Veronica A., et al.
Publicado: (2019)

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
por: Caracciolo, Daniele, et al.
Publicado: (2021)

Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
por: Quattrone, Martina, et al.
Publicado: (2023)

The Role of Monoclonal Antibodies in the Management of Leukemia
por: Al-Ameri, Ali, et al.
Publicado: (2010)

New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Gallazzi, Marco, et al.
Publicado: (2022)

Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
por: Mejía-Aranguré, Eréndira, et al.
Publicado: (2022)

Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia
por: Bárcenas-López, Diego Alberto, et al.
Publicado: (2020)

Modern Immunotherapy of Adult B-Lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells
por: Maino, Elena, et al.
Publicado: (2015)

Recent updates for antibody therapy for acute lymphoblastic leukemia
por: Li, Le, et al.
Publicado: (2020)

Venetoclax: evidence to date and clinical potential
por: Juárez-Salcedo, Luis Miguel, et al.
Publicado: (2019)

A monoclonal antibody to common acute lymphoblastic leukemia antigen (CALLA) and its expression on several human tumor cell lines.
por: Park, W. S., et al.
Publicado: (1992)

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
por: Chenbah, Wafa, et al.
Publicado: (2023)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review
por: Bohra, Chandrashekar, et al.
Publicado: (2017)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Recent advances in the management of pediatric acute lymphoblastic leukemia
por: Starý, Jan, et al.
Publicado: (2016)

Regarding management of COVID-19 in acute lymphoblastic leukemia
por: Ammad Ud Din, Mohammad
Publicado: (2022)

Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors
por: Stein, Anthony S., et al.
Publicado: (2018)

Acute Lymphoblastic Leukemia Following Incomplete Kawasaki Disease
por: Garcia-Dominguez, Miguel, et al.
Publicado: (2020)

New concepts in acute lymphoblastic leukemia frontline trials
por: Oskarsson, Trausti, et al.
Publicado: (2018)

Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell–Redirected Bispecific Antibodies
por: Lussana, Federico, et al.
Publicado: (2021)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment
por: Juárez-Salcedo, Luis Miguel, et al.
Publicado: (2018)

Trends in management of acute lymphoblastic leukemia: Influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia
por: Arigela, Ravi Sankar, et al.
Publicado: (2016)

MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia
por: Mendiola-Soto, Diana Karen, et al.
Publicado: (2023)

Evaluation and management of measurable residual disease in acute lymphoblastic leukemia
por: Abou Dalle, Iman, et al.
Publicado: (2020)

COVID-19 and adult acute lymphoblastic leukemia: Presentation and management
por: Butt, Ayesha, et al.
Publicado: (2021)

Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia: A Work in Progress
por: Molica, Matteo, et al.
Publicado: (2023)

The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lato, Marta Weronika, et al.
Publicado: (2021)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Gibson, Amber, et al.
Publicado: (2021)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia
por: Yang, Lihua, et al.
Publicado: (2015)

Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies
por: Dave, Hema, et al.
Publicado: (2012)

Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia
por: Liu, Delong, et al.
Publicado: (2019)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017)

Acute lymphoblastic leukemia: age and biology
por: Foà, Robin
Publicado: (2011)

Pathogenesis and prognostication in acute lymphoblastic leukemia
por: Zuckerman, Tsila, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6bbobdh4k3is3ceapa2jp55822